The device was approved by the U.S. Food and Drug Administration in December, with some experts hailing it as a milestone in therapy for people with spinal cord injuries.

The Michael J. Fox Foundation for Parkinson's Research is supporting a study addressing mobility challenges in Parkinson's disease; the first participant was enrolled in late 2024 A US Department of ...

The Michael J. Fox Foundation for Parkinson's Research is supporting a study addressing mobility challenges in Parkinson's ...